About
Cape Europe AE Ltd was created in 2005 to provide users of isolator technology and other types of controlled environments qualification, validation and bio-decontamination cycle development expertise. Thanks to its steady progress, in 2010, the company was able to extend its activities to include the design, patenting, manufacture and supply of a complete range of new innovative rapid transfer ports. In 2021, Cape Europe AE officially joined forces with a multi million-dollar turnover pharmaceutical equipment supplier. The name of the new joint venture formed between the two companies is CAPE Europe Ltd.
Technologies
Bootstrap Framework
Google Font API
reCAPTCHA
Apache
Mobile Friendly
WordPress.org
Keywords
vhp technology & cycle development
rapid transfer ports
isolators
rapid transfer system
bio-decontamination system integration
biotechnology
bio-decontamination cycle development
containment solutions
pharmaceutical manufacturing
bio-decontamination cycle
sterility assurance
environmental monitoring
bio-decontamination for bsl3/4 environments
pharmaceutical transfer technology
externally operated transfer port
regulatory compliance
vhp bio-decontamination systems
controlled environment transfer
autoclavable components
bio-decontamination cycle optimization
distribution
bio-decontamination in research labs
medical equipment and supplies manufacturing
manufacturing
recyclable materials
b2b
bio-decontamination process validation
compatibility with dpte getinge
research laboratory solutions
bio-decontamination validation services
Company Information
-
Employees 3
-
Founded 2005
Location
14 Rue Roger Salengro, Saint-Ouen, Centre-Val de Loire, France, 41100
